Lactose (India) Ltd.

BSE: LACTOSE524202ISIN INE058I01013

Healthcare
Pharmaceuticals

Share price

₹104.10-1.45 (-1.37%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹136.45
52W low: ₹76.01
Off 52W high: -23.71%
1M return: -2.66%
3M return: +2.56%
6M return: -11.03%
1Y return: -7.88%
20D avg volume: 5,217
50 DMA: ₹104.04
200 DMA: ₹102.51

Key ratios Standalone

Market cap: ₹131.05 Cr
Current price: ₹104.10
52W high / low: ₹136.45 / ₹76.01
Face value: ₹10.00
P/E: 18.93
P/B: 2.55
EPS (TTM): ₹5.50
Book value / share: ₹40.82
ROE: 13.48%
ROCE: 14.70%
Operating margin: 14.13%
Net margin: 5.04%
Debt / equity: 0.95
Net debt: ₹61.13 Cr
Interest cover: 2.69
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 115.7 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	46.97	45.77	36.77	41.18	39.58	27.77	28.72	30.45	29.46	—
	0.56	0.22	0.63	0.37	0.41	0.37	0.56	0.30	0.22	—
	47.53	45.98	37.40	41.55	39.99	28.14	29.28	30.75	29.68	—
	44.30	43.67	36.52	38.41	37.70	27.59	28.75	28.14	26.46	—
	32.49	28.28	21.30	22.30	15.64	17.76	14.12	16.14	12.50	—
	0.00	0.00	0.00	0.73	0.00	0.00	—	—	—	—
	4.21	3.53	3.57	3.54	3.44	3.35	3.16	3.00	2.91	—
	1.76	1.43	1.39	1.04	1.22	1.84	1.64	1.37	1.26	—
	1.64	1.50	1.43	1.44	1.37	1.39	1.35	1.33	1.31	—
	10.32	9.97	9.39	9.36	8.40	8.80	2.39	2.39	2.34	—
	3.23	2.31	0.88	3.14	2.29	0.55	0.53	2.61	3.23	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	3.23	2.31	0.88	3.14	2.29	0.55	0.53	2.61	3.23	—
	0.87	0.43	0.35	0.99	0.79	0.09	0.32	0.57	0.96	—
	2.37	1.88	0.53	2.16	1.50	0.64	0.22	2.03	2.27	—
	1.88	1.49	0.42	1.71	1.19	0.51	0.17	1.61	1.80	—
Key metrics
	6.63	5.24	3.70	5.62	4.88	3.78	3.52	5.31	5.80	—
	14.10%	11.40%	10.10%	13.60%	12.30%	13.60%	12.30%	17.40%	19.70%	—
	5.00%	4.10%	1.40%	5.20%	3.80%	2.30%	0.80%	6.70%	7.70%	—
	—	4.00%	—	4.50%	—	2.70%	—	—	—	—
	18.70%	64.80%	28.00%	35.20%	34.40%	—	—	—	—	—
	58.00%	193.70%	140.90%	6.40%	-33.90%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	170.69	163.29	116.40	—
	1.78	1.07	1.45	—
	172.46	164.36	117.85	—
	162.90	155.74	110.94	—
	104.37	87.52	60.51	—
	0.73	0.00	0.00	—
	14.85	14.08	12.41	—
	5.62	5.09	6.10	—
	6.01	5.74	5.39	—
	39.04	36.55	34.66	—
	9.56	8.62	6.92	—
	0.00	0.00	0.00	—
	9.56	8.62	6.92	—
	2.64	2.56	1.75	—
	6.94	6.06	5.16	—
	5.50	4.82	4.10	—
Key metrics
	21.19	19.45	18.41	—
	12.41%	11.90%	15.80%	—
	4.07%	3.70%	4.40%	—
	—	14.70%	14.70%	—
	34.91%	40.30%	—	—
	58.09%	17.40%	—	—
	—	-4.92	-14.67	—
	—	0.92	-0.06	—
	—	0.95	0.96	—
	—	61.13	51.71	—
	—	115.7	111.5	—
Balance sheet
	—	183.23	133.47	—
	—	98.62	57.33	—
	—	0.53	4.48	—
	—	33.46	21.64	—
	—	55.95	24.55	—
	—	6.31	4.51	—
	—	68.22	51.69	—
	—	37.68	10.64	—
	—	89.80	44.89	—
	—	61.66	56.19	—
	—	38.80	30.31	—
	—	22.86	25.88	—
	—	64.79	58.74	—
Cash flow
	—	5.56	-0.29	—
	—	-10.22	-15.57	—
	—	0.71	18.81	—
	—	10.48	14.38	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +34.91%
Profit YoY (TTM): +58.09%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 53.65%

Quarter	September 2026	June 2026
Promoter %	53.65%	53.65%

Holder	Type	Holding	Previous	Change
SANGITA MAHESHWARI	Promoter	30.73%	30.73%	0.00%
ATUL MAHESHWARI	Promoter	11.21%	11.21%	0.00%
SHYAMSUNDER BHORILAL TOSHNIWAL	Promoter Group	10.53%	10.53%	0.00%
MADHUSHA HOLDINGS PRIVATE LIMITED	Public	3.99%	3.99%	0.00%
Keshav Garg	Public	1.03%	—	—
JAIKAAY TRADEVENTURE PRIVATE LIMITED	Public	1.01%	1.04%	-0.03%
PUSHPA SURAJ MAHESHWARI	Promoter	0.90%	0.90%	0.00%
YASHVARDHAN MAHESHWARI	Promoter	0.28%	0.28%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Lactose (India) Ltd. S	131	104.10	18.93	14.70%	+34.91% TTM	+58.09% TTM	-7.88%

Filings & corporate actions

Recent announcements

With reference to the Scheme of Amalgamation NCLT order dated 05th August 202621 Oct 2026 · Others / Outcome without intimation
Pursuant to Regulation 74(5) of SEBI(DP) Regulations, 2018 we hereby submit the Compliance certificate.14 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to the provisions of the SEBI (LODR) Regulations, 2015 we hereby submit the voting results for the AGM held on 30th September 20261 Oct 2026 · AGM/EGM / AGM
Pursuant to Regulation 30 & 44(3) of SEBI (LODR) Regulations , 2015 we hereby submit the Scrutinizer Report for the AGM held on 30th September, 20261 Oct 2026 · AGM/EGM / AGM
Pursuant to Regulation 30 of SEBI (LODR) 2015, we hereby submit the intimation towards Appointment of Cost Auditor of the Company.30 Sep 2026 · Company Update / Change in Management
We hereby submit the proceedings of the 35th Annual General Meeting of the Company held on Wednesday, 30th September, 202630 Sep 2026 · AGM/EGM / AGM
Intimation of Closure of Trading Window -approval of Unaudited Financial Results for the Quarter ended 30th September 202629 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Pursuant to the Regulation 30 and 47(3) of SEBI (LODR) Regulations,2015 we hereby submit the newspaper publication for intimation of upcoming AGM.8 Sep 2026 · Company Update / Newspaper Publication
Pursuant to the provision of SEBI(LODR) Regulation, 2015, we hereby submit the intimation of Book closure, fixation of cut-off Date for E-voting , period of Remote E-voting for upcoming ....7 Sep 2026 · Corp. Action / Book Closure
Pursuant to the provisions of SEBI (LODR) Regulation ,2015 , We hereby submit the intimation towards Annual General Meeting of the Company scheduled to be held on Wednesday 30th September 20267 Sep 2026 · AGM/EGM / AGM
Pursuant to Regulation 34(1) of SEBI (LODR) Regulations, 2015, we hereby submit the Annual Report for the FY 2025-26.7 Sep 2026 · Others / Reg. 34 (1) Annual Report
Pursuant to Regulation 30 and 47(3) of SEBI (LODR) Regulations,2015 we hereby submit the newspaper publication for Pre-dispatch of Annual Report along the Notice of the upcoming AGM.7 Sep 2026 · Company Update / Newspaper Publication
Pursuant to the Regulation 30 and 47(3) of SEBI (LODR) Regulations, 2015 we hereby submit the newspaper publication for Pre-dispatch of Annual Report along the Notice of the upcoming AGM.7 Sep 2026 · Company Update / Newspaper Publication
Intimation of Effective date of Amalgamation5 Sep 2026 · Company Update / General
Intimation of Effective Date of Amalgamation5 Sep 2026 · Company Update / Scheme of Arrangement
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 we hereby submit the disclosure towards the Appointment of Internal Auditor And Cost Auditor.25 Aug 2026 · Company Update / Change in Management
In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform Stock Exchange that the ....25 Aug 2026 · Others / Outcome without intimation
In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform Stock Exchange that the ....25 Aug 2026 · Others / Outcome without intimation
Scheme of Amalgamation has been sanctioned by Hon''ble NCLT Ahmedabad Bench. The Certified True copy of the NCLT order has been received by the Company on 20th August 2026.20 Aug 2026 · Company Update / Scheme of Arrangement
Scheme of Amalgamation has been sanctioned Hon''ble NCLT Ahmedabad Bench. The Certified True Copy of the NCLT order has been received to the Company on 20th August 2026.20 Aug 2026 · Company Update / General
Pursuant to Regulation 30 and 47(3) SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR) , we hereby submit the newspaper Publication of Un-audited financial ....13 Aug 2026 · Company Update / Newspaper Publication
Pursuant to Regulation 30 and 47(3) SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR) , we hereby submit the newspaper Publication of Un-audited financial ....13 Aug 2026 · Company Update / Newspaper Publication
We are submitting the Un audited Financial Result along with Auditor report of the Company for first quarter ended as on 30th June 202611 Aug 2026 · Result / Financial Results
In compliance with Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform to the Exchange ....11 Aug 2026 · Board Meeting / Outcome of Board Meeting
Lactose India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve 1. To consider and approve Un-Audited ....6 Aug 2026 · Board Meeting / Board Meeting
Pursuant to Regulation 30 of SEBI (LODR)Regulations , 2015 , we hereby submit the credit rating letter received from CRISIL Ratings Limited.14 Jul 2026 · Company Update / Credit Rating
Pursuant to Regulation 74(5) of SEBI (DP) Regulation, 2018, we hereby submit the certificate issued by RTA.13 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We hereby submit the intimation towards closure of Trading Window for the First Quarter Ended 30th June, 202629 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Considered and Approved the Forfeiture of Convertible Warrants ('Warrants') which the Company, had issued and allotted 15,00,000 Convertible Warrants, on preferential basis to following ....18 Jun 2026 · Board Meeting / Outcome of Board Meeting
Lactose India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/06/2026 ,inter alia, to consider and approve 1.To forfeit 15,00,000 (Fifteen ....15 Jun 2026 · Board Meeting / Board Meeting
We hereby submit Annual Secretarial Compliance report for financial year ended 31st March 2026.28 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
We hereby submit Annual Secretarial Compliance report for financial year ended 31st March 2026.28 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 30 & 47(3) of SEBI (LODR) Regulations, 2015 we hereby submit the newspaper publication of financial results for quarter and year ended 31st March, 2026.21 May 2026 · Company Update / Newspaper Publication
We hereby submit the Financial Results for the Quarter and Financial Year Ended 31st March, 2026 along with the Independent Auditor''s Report20 May 2026 · Result / Financial Results
In compliance with Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Board of ....20 May 2026 · Board Meeting / Outcome of Board Meeting
Lactose India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve 1. Audited Financial Results ....15 May 2026 · Board Meeting / Board Meeting
We hereby submit our clarification on significant price movement of the company''s security. Kindly take the same on record and oblige.29 Apr 2026 · Company Update / General
The Exchange has sought clarification from Lactose India Ltd on April 24, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....24 Apr 2026 · Company Update / Clarification
Pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018 we hereby submit the certificate issued by RTA.13 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Disclosure of Voting Results of the Extra Ordinary General Meeting of the Company held on 28th March 202630 Mar 2026 · AGM/EGM / Court Convened Meeting

Corporate actions

Purpose	Ex date	Record date	Payment date
E.G.M.	8 Nov 2024	—	—

Board meetings

11 Aug 2026 Board Meeting - Financial Results